(E)-2-(2-methoxyphenyl)ethenesulfonyl chloride | 1161945-16-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: (E)-2-(2-methoxyphenyl)ethenesulfonyl chloride
• CAS: 1161945-16-9
• 化学式: C₉H₉ClO₃S
• 分子量: 232.688
• InChiKey: DEDFXMJWTVBWDG-VOTSOKGWSA-N

物化性质

• 沸点：
  361.3±34.0 °C(predicted)
• 密度：
  1.366±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.11
• 拓扑面积：
  51.8
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (E)-2-(2-methoxyphenyl)ethenesulfonyl chloride 在 copper(I) oxide 、 sodium metabisulfite 、 五甲基二乙烯三胺 、 potassium carbonate 作用下， 以 甲醇 、 二氯甲烷 、 二甲基亚砜 、 乙腈 为溶剂， 反应 24.17h， 生成 (E)-3,3-difluoro-5-(2-methoxystyryl)-1-methylpiperidin-2-one
  参考文献：
  名称：

  Desulfonylation-Initiated Distal Alkenyl Migration in Copper-Catalyzed Alkenylation of Unactivated Alkenes

  摘要：

  A novel and efficient protocol for desulfonylation-initiated distal alkenyl migration and its application to the elusive alkenylation of unactivated alkenes have been presented. This radical cascade process has successfully achieved the vicinal difluoroalkylalkenylation of unactivated alkenes with excellent chemo-, regio-, and stereoselectivity in high efficiency under mild conditions. The reactions afford previously unknown 3,3-difluoro-S-styrylpiperidin-2-one derivatives or beta-styryl-gamma-difluoroalkyl amines bearing a quaternary stereocenter. This is the first report of difunctionalization of unactivated alkenes through desulfonylation-initiated distal alkenyl migration.

  DOI：

  10.1021/acs.orglett.8b02840
• 作为产物：
  描述：

  2-甲氧基苯乙烯 在 氯化亚砜 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 4.0h， 生成 (E)-2-(2-methoxyphenyl)ethenesulfonyl chloride
  参考文献：
  名称：

  Desulfonylation-Initiated Distal Alkenyl Migration in Copper-Catalyzed Alkenylation of Unactivated Alkenes

  摘要：

  A novel and efficient protocol for desulfonylation-initiated distal alkenyl migration and its application to the elusive alkenylation of unactivated alkenes have been presented. This radical cascade process has successfully achieved the vicinal difluoroalkylalkenylation of unactivated alkenes with excellent chemo-, regio-, and stereoselectivity in high efficiency under mild conditions. The reactions afford previously unknown 3,3-difluoro-S-styrylpiperidin-2-one derivatives or beta-styryl-gamma-difluoroalkyl amines bearing a quaternary stereocenter. This is the first report of difunctionalization of unactivated alkenes through desulfonylation-initiated distal alkenyl migration.

  DOI：

  10.1021/acs.orglett.8b02840

文献信息

• Bis-(Sulfonylamino) Derivatives in Therapy 205
  申请人：Bylund Johan

  公开号：US20090163586A1

  公开（公告）日：2009-06-25

  The invention provides compounds of formula (I) wherein R 1 , R 3 , L 1 , L 2 , G 1 , G 2 , A and m are as defined in the specification and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof; together with processes for their preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are inhibitors of microsomal prostaglandin E synthase-1.

  该发明提供了式（I）的化合物 其中R 1 ，R 3 ，L 1 ，L 2 ，G 1 ，G 2 ，A和m如规范中定义的那样，以及其光学异构体，消旋体和互变异构体，以及其药学上可接受的盐；以及它们的制备方法，含有它们的药物组合物以及它们在治疗中的应用。这些化合物是微粒体前列腺素E合成酶-1的抑制剂。
• Bis-(sulfonylamino) derivatives for use in therapy
  申请人：Bylund Johan

  公开号：US09145380B2

  公开（公告）日：2015-09-29

  The invention provides compounds of formula (I) wherein R1, R3, L1, L2, G1, G2, A and m are as defined in the specification and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof; together with processes for their preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are inhibitors of microsomal prostaglandin E synthase-1.

  本发明提供了式（I）的化合物，其中R1、R3、L1、L2、G1、G2、A和m如规范中所定义，并提供其光学异构体、外消旋体和互变异构体，以及其药学上可接受的盐；以及制备它们的方法、包含它们的制药组合物和它们在治疗中的用途。这些化合物是微粒体前列腺素E合成酶-1的抑制剂。
• Bis-(Sulfonylamino) derivatives for use in therapy
  申请人：Bylund Johan

  公开号：US20100331321A1

  公开（公告）日：2010-12-30

  The invention provides compounds of formula (I) wherein R 1 ,R 3 ,L 1 ,L 2 ,G 1 ,G 2 , A and m are as defined in the specification and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof; together with processes for their preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are inhibitors of microsomal prostaglandin E synthase-1.

  本发明提供了式（I）的化合物，其中R1，R3，L1，L2，G1，G2，A和m如规范中所定义，并且其光学异构体，外消旋体和互变异构体以及其药学上可接受的盐；以及其制备过程，含有它们的药物组合物以及它们在治疗中的用途。这些化合物是微粒体前列腺素E合成酶-1的抑制剂。
• BIS- (SULF ONYLAMINO) DERIVATIVES FOR USE IN THERAPY
  申请人：AstraZeneca AB

  公开号：EP2234993A1

  公开（公告）日：2010-10-06
• US9145380B2
  申请人：——

  公开号：US9145380B2

  公开（公告）日：2015-09-29